Cargando…
Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
OBJECTIVE: To assess the efficacy and safety of MK-0941, a glucokinase activator (GKA), when added to stable-dose insulin glargine in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: In this double-blind study, 587 patients taking stable-dose insulin glargine (±metformin ≥1,500 mg/day) we...
Autores principales: | Meininger, Gary E., Scott, Russell, Alba, Maria, Shentu, Yue, Luo, Edmund, Amin, Himal, Davies, Michael J., Kaufman, Keith D., Goldstein, Barry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220852/ https://www.ncbi.nlm.nih.gov/pubmed/21994424 http://dx.doi.org/10.2337/dc11-1200 |
Ejemplares similares
-
GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway
por: Chen, Haifeng, et al.
Publicado: (2022) -
Insulin-Receptor Substrate-2 (IRS-2) Is Required for Maintaining Glucokinase and Glucokinase Regulatory Protein Expression in Mouse Liver
por: Roncero, Isabel, et al.
Publicado: (2013) -
Role of Glucokinase in the Subcellular Localization of Glucokinase Regulatory Protein
por: Jin, Ling, et al.
Publicado: (2015) -
Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis
por: Ma, Yue, et al.
Publicado: (2018) -
Polymorphism of Glucokinase Gene in Non-Insulin Dependent Diabetes Mellitus
por: Kim, Deog-Yoon, et al.
Publicado: (1994)